GSK Plc, Pfizer Inc. and other drugmakers must face trials in state court in Delaware after a judge found the evidence ...
The Delaware State Court ruled that expert witnesses can present scientific evidence in the roughly 75,000 cases relating to ...
GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim ...
GSK results from a Phase 2 study that found Jemperli showed a 100% clinical complete response rate in patients with mismatch ...
Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.
GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face ...
, opens new tab dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for ...
June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may ...
SAN FRANCISCO (Reuters) - Elon Musk ignored repeated warnings about the U.S. securities disclosure obligations potentially ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in ...